查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600887

糖化白蛋白检测法市场：按产品、应用和最终用户划分 - 2025-2030 年全球预测

Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年糖化白蛋白检测法市场价值为2.1729亿美元，预计到2024年将达到2.3269亿美元，复合年增长率为7.51%，预计到2030年将达到3.6092亿美元。

糖化白蛋白检测法市场的定义是对测量糖化白蛋白水平以监测和管理糖尿病状况的诊断测试的需求。对这些测试的需求源于它们在填补 HbA1c 测试留下的空白方面的作用，HbA1c 测试提供长期血糖值资料，并提供准确的短期血糖控制评估。这些测试对于患有影响红血球寿命的疾病的患者或接受透析的患者特别有用。最终使用范围主要是专注于糖尿病综合管理和相关代谢疾病的医院、诊断实验室和研究机构。

主要市场统计
基准年[2023] 21729万美元
预测年份 [2024] 23269万美元
预测年份 [2030] 36092万美元
复合年增长率（%） 7.51%

推动糖化白蛋白检测法市场的关键成长要素包括全球糖尿病盛行率的不断上升、人们对早期检测方法的认识不断提高，以及检测试剂套件的技术进步，提高了准确性和易用性。在新兴市场，糖尿病盛行率不断上升，医疗基础设施正在加强，以适应更先进的诊断工具，因此存在着增加采用的新机会。医疗机构和检测开发商之间的合作可能会推动市场扩张，而专注于使用更快、更具成本效益的套件进行广泛筛检的产品开拓具有广泛的成长潜力。

影响市场成长的挑战和限制包括与检测试剂套件相关的高成本以及与 HbA1c 等既定指标相比，医疗保健专业人员对糖化白蛋白检测的认识较低。此外，一些地区的监管障碍可能会延迟新产品的市场进入。专注于降低成本、提高测量准确性的研究以及针对医疗保健专业人员的综合教育计划可能会解决这些障碍。

最佳创新领域包括整合数位健康平台和指标，以即时监测和管理糖尿病患者，以提高患者参与度和治疗结果。由于市场竞争激烈，并且随着技术进步而迅速发展，透过策略伙伴关係和检测开发的持续创新，存在成长潜力。

市场动态：快速发展的糖化白蛋白检测法市场的关键市场洞察

供需的动态交互作用正在改变糖化白蛋白检测法市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球糖尿病盛行率上升
    • 政府针对早期糖尿病筛检计画的倡议
  • 市场限制因素
    • 糖化白蛋白检测的技术局限性
  • 市场机会
    • 技术进步提高了测量技术的准确性和灵敏度
    • 就地检验(POCT) 的开发与扩展使用
  • 市场挑战
    • 替代技术的意识和存在程度较低

波特五力：驾驭糖化白蛋白检测法市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解糖化白蛋白检测法市场的外部影响

外部宏观环境因素在塑造糖化白蛋白检测法市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解糖化白蛋白检测法市场的竞争状况

对糖化白蛋白检测法市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵糖化白蛋白检测法市场供应商的绩效评估

FPNV定位矩阵是评估糖化白蛋白检测法市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，为糖化白蛋白检测法市场的成功指明道路

对于旨在加强在全球市场的影响力的公司来说，糖化白蛋白检测法市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的糖尿病盛行率正在上升
      • 政府关于早期糖尿病筛检计画的倡议
    • 抑制因素
      • Glico检测的技术限制
    • 机会
      • 技术进步改进了分析方法，提高了准确性和灵敏度
      • 开发并增加 GA就地检验(POCT) 的使用
    • 任务
      • 对替代技术的认识和存在有限
  • 市场区隔分析
    • 产品：增加动物糖化白蛋白检测法的使用，以了解疾病机制
    • 应用：糖化白蛋白检测法广泛应用于第1型糖尿病的检测，以预防健康併发症。
    • 最终使用者：诊断实验室中糖化白蛋白检测法的高使用率
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章糖化白蛋白检测法市场：副产品

  • 动物糖化白蛋白检测法
  • 人类糖化白蛋白检测法

第七章糖化白蛋白检测法市场：依应用分类

  • 糖尿病前期
  • 1型糖尿病
  • 2型糖尿病

第 8 章 糖化白蛋白检测法市场：依最终用户分类

  • 糖尿病护理中心
  • 诊断实验室
  • 医院/诊所

第九章北美和南美糖化白蛋白检测法市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区糖化白蛋白检测法市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲糖化白蛋白检测法市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • John Lewis 和 Randox 之间的开创性合作推出店内血液检测以加强健康检查
    • 印度控製糖尿病和高血压的策略性倡议
    • 1 型糖尿病治疗的进展：Enable Biosciences 推出采用 ADAP 技术的创新「Kit to Clinics」计划
    • 生物技术领域的开创性创新：WRCP IIT 教员因生物技术津贴点火器的成就而奖励
    • ELSA 研究：英国儿童第 1 型糖尿病早期检测和管理的开创性研究
    • Precision Diabetes, Inc. 与 DxGen Corp. 合作，推出 Epithod AutoDx，彻底改变照护现场糖尿病检测
    • EKF Diagnostics 推出 FDA核准的LucicaGlicoL检测套组简介
  • 战略分析和建议
    • 艾博康
    • 旭化成株式会社
    • 康德乐
    • 迪亚酶实验室有限公司
    • EKF 诊断控股有限公司
    • 埃派尼克斯诊断公司
    • 美国实验室控股公司
    • 工业工业株式会社
    • 库萨比欧科技有限公司
    • 赛默飞世尔科技有限公司

公司名单

  • Abbexa Limited
  • Abcam PLC
  • Abnova Corporation
  • AFG Bioscience LLC
  • Asahi Kasei Corporation
  • Beijing Jiuqiang Biotechnology Co., Ltd.
  • Biomatik Corporation
  • Cardinal Health, Inc.
  • Crystal Chem Inc.
  • Cusabio Technology LLC
  • Diazyme Laboratories, Inc.
  • DxGen Corp.
  • EKF Diagnostics Holdings
  • Epinex Diagnostics Inc.
  • Hzymes Biotech
  • Laboratory Corporation of America Holdings
  • LifeSpan BioSciences, Inc.
  • Merck KGaA
  • Novatein Biosciences Inc.
  • Sekisui Chemical Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Thomas Scientific LLC
  • Weldon Biotech, Inc.
  • Wuhan Fine Biotech Co., Ltd.
Product Code: MRR-A579C431592C

The Glycated Albumin Assay Market was valued at USD 217.29 million in 2023, expected to reach USD 232.69 million in 2024, and is projected to grow at a CAGR of 7.51%, to USD 360.92 million by 2030.

The Glycated Albumin Assay market is defined by the demand for diagnostic tests that measure glycated albumin levels to monitor and manage diabetic conditions. The necessity of these assays arises from their role in providing accurate, short-term glycemic control assessments, bridging the gap left by HbA1c tests, which offer long-term glucose level data. These assays are particularly useful for patients with conditions that affect red blood cell lifespan or undergoing dialysis, where HbA1c might give skewed results. End-use scope primarily spans hospitals, diagnostic laboratories, and research institutions focusing on comprehensive diabetes management and related metabolic disorders.

KEY MARKET STATISTICS
Base Year [2023] USD 217.29 million
Estimated Year [2024] USD 232.69 million
Forecast Year [2030] USD 360.92 million
CAGR (%) 7.51%

Key growth factors driving the glycated albumin assay market include the increasing prevalence of diabetes globally, rising awareness for early detection methods, and technological advancements in assay kits improving accuracy and ease of use. Novel opportunities lie in expanding adoption across emerging markets where diabetes prevalence is climbing, and healthcare infrastructures are strengthening to accommodate more sophisticated diagnostic tools. Collaborations between healthcare institutions and assay developers could foster market expansion, while product development focusing on faster, more cost-effective kits for widespread screening poses promising growth potential.

Challenges and limitations impacting market growth include the high costs associated with assay kits and limited awareness amongst healthcare professionals about glycated albumin testing relative to more established metrics like HbA1c. Additionally, regulatory hurdles in different regions can delay market entry for newer products. Research focusing on reducing costs, improving assay accuracy, and comprehensive education programs directed at healthcare professionals could address these barriers.

Best areas of innovation include integrating digital health platforms with assay results for real-time monitoring and management of diabetic patients, thus enhancing patient engagement and outcomes. The market's nature is competitive and rapidly evolving with technological advancements, indicating potential for growth through strategic partnerships and continuous innovation in assay development.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glycated Albumin Assay Market

The Glycated Albumin Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of diabetes worldwide
    • Government initiatives for early diabetes screening programs
  • Market Restraints
    • Technical limitations of glycated albumin testing
  • Market Opportunities
    • Advancements in technology for improved assay methodologies with enhanced accuracy and sensitivity
    • Growing development and use of point-of-care testing (POCT) of GA
  • Market Challenges
    • Limited awareness and presence of alternative techniques

Porter's Five Forces: A Strategic Tool for Navigating the Glycated Albumin Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glycated Albumin Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glycated Albumin Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glycated Albumin Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glycated Albumin Assay Market

A detailed market share analysis in the Glycated Albumin Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glycated Albumin Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glycated Albumin Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glycated Albumin Assay Market

A strategic analysis of the Glycated Albumin Assay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glycated Albumin Assay Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam PLC, Abnova Corporation, AFG Bioscience LLC, Asahi Kasei Corporation, Beijing Jiuqiang Biotechnology Co., Ltd., Biomatik Corporation, Cardinal Health, Inc., Crystal Chem Inc., Cusabio Technology LLC, Diazyme Laboratories, Inc., DxGen Corp., EKF Diagnostics Holdings, Epinex Diagnostics Inc., Hzymes Biotech, Laboratory Corporation of America Holdings, LifeSpan BioSciences, Inc., Merck KGaA, Novatein Biosciences Inc., Sekisui Chemical Co., Ltd., Thermo Fisher Scientific Inc., Thomas Scientific LLC, Weldon Biotech, Inc., and Wuhan Fine Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Glycated Albumin Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Animal Glycated Albumin Assay and Human Glycated Albumin Assay.
  • Based on Application, market is studied across Prediabetes, Type 1 Diabetes, and Type 2 Diabetes.
  • Based on End User, market is studied across Diabetic Care Centres, Diagnostic Laboratories, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of diabetes worldwide
      • 5.1.1.2. Government initiatives for early diabetes screening programs
    • 5.1.2. Restraints
      • 5.1.2.1. Technical limitations of glycated albumin testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technology for improved assay methodologies with enhanced accuracy and sensitivity
      • 5.1.3.2. Growing development and use of point-of-care testing (POCT) of GA
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and presence of alternative techniques
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing use of animal glycated albumin assay to understand disease mechanisms
    • 5.2.2. Application: Significant adoption of glycated albumin assay for detection of type 1 diabetes owing to prevent health complications
    • 5.2.3. End User: High usage of glycated albumin assay in diagnostic laboratories
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Glycated Albumin Assay Market, by Product

  • 6.1. Introduction
  • 6.2. Animal Glycated Albumin Assay
  • 6.3. Human Glycated Albumin Assay

7. Glycated Albumin Assay Market, by Application

  • 7.1. Introduction
  • 7.2. Prediabetes
  • 7.3. Type 1 Diabetes
  • 7.4. Type 2 Diabetes

8. Glycated Albumin Assay Market, by End User

  • 8.1. Introduction
  • 8.2. Diabetic Care Centres
  • 8.3. Diagnostic Laboratories
  • 8.4. Hospitals & Clinics

9. Americas Glycated Albumin Assay Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Glycated Albumin Assay Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Glycated Albumin Assay Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Pioneering Partnership Between John Lewis and Randox Unveils In-Store Blood Testing to Enhance Health Diagnostics
    • 12.3.2. Strategic Initiatives to Combat Diabetes and Hypertension in India
    • 12.3.3. Advancing Type 1 Diabetes Care: Enable Biosciences Launches Innovative 'Kit to Clinics' Program Featuring ADAP Technology
    • 12.3.4. Pioneering Innovations in Biotechnology: Recognizing the Achievements of WRCP IIT Faculty in Securing Biotechnology Ignition Grants
    • 12.3.5. ELSA Study: Pioneering Early Detection and Management of Type 1 Diabetes in UK Children
    • 12.3.6. Precision Diabetes, Inc. Partners with DxGen Corp. to Revolutionize Point-of-Care Diabetes Testing with the Launch of Epithod AutoDx
    • 12.3.7. Introduction of the FDA-Cleared Lucica Glycated Albumin-L Test Kit by EKF Diagnostics
  • 12.4. Strategy Analysis & Recommendation
    • 12.4.1. Abcam PLC
    • 12.4.2. Asahi Kasei Corporation
    • 12.4.3. Cardinal Health, Inc.
    • 12.4.4. Diazyme Laboratories, Inc.
    • 12.4.5. EKF Diagnostics Holdings PLC
    • 12.4.6. Epinex Diagnostics Inc.
    • 12.4.7. Laboratory Corporation of America Holdings
    • 12.4.8. Sekisui Chemical Co., Ltd.
    • 12.4.9. Cusabio Technology LLC
    • 12.4.10. Thermo Fisher Scientific Inc.

Companies Mentioned

  • 1. Abbexa Limited
  • 2. Abcam PLC
  • 3. Abnova Corporation
  • 4. AFG Bioscience LLC
  • 5. Asahi Kasei Corporation
  • 6. Beijing Jiuqiang Biotechnology Co., Ltd.
  • 7. Biomatik Corporation
  • 8. Cardinal Health, Inc.
  • 9. Crystal Chem Inc.
  • 10. Cusabio Technology LLC
  • 11. Diazyme Laboratories, Inc.
  • 12. DxGen Corp.
  • 13. EKF Diagnostics Holdings
  • 14. Epinex Diagnostics Inc.
  • 15. Hzymes Biotech
  • 16. Laboratory Corporation of America Holdings
  • 17. LifeSpan BioSciences, Inc.
  • 18. Merck KGaA
  • 19. Novatein Biosciences Inc.
  • 20. Sekisui Chemical Co., Ltd.
  • 21. Thermo Fisher Scientific Inc.
  • 22. Thomas Scientific LLC
  • 23. Weldon Biotech, Inc.
  • 24. Wuhan Fine Biotech Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLYCATED ALBUMIN ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. GLYCATED ALBUMIN ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GLYCATED ALBUMIN ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GLYCATED ALBUMIN ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GLYCATED ALBUMIN ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLYCATED ALBUMIN ASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY ANIMAL GLYCATED ALBUMIN ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY HUMAN GLYCATED ALBUMIN ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY DIABETIC CARE CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. GLYCATED ALBUMIN ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. GLYCATED ALBUMIN ASSAY MARKET, FPNV POSITIONING MATRIX, 2023